Zusammenfassung
The efficacy of ceftriaxone in eliminating nasopharyngeal carriage of Neisseria meningitidis was compared with that of rifampicin during an epidemic of serogroup B meningococcal disease in Auckland, New Zealand. Household contacts of cases had a throat swab taken and were randomized to treatment. Carriers had a repeat swab taken 6 days later to determine efficacy of treatment. Ceftriaxone (98.2\%) was equivalent to rifampicin (97.6\%) in eliminating serogroup B N. meningitidis. It is cheaper than rifampicin and has the advantage of full compliance and fewer contraindications, but its acceptability by patients may limit its use as a first-line prophylactic agent.
- adolescent,
- adult,
- antibiotics,
- antitubercular,
- carrier
- ceftriaxone,
- cephalosporins,
- child,
- humans,
- infant,
- infections,
- meningitidis,
- meningococcal
- nasopharynx,
- neisseria
- newborn,
- preschool,
- rifampin,
- serotyping
- state,
Nutzer